Q1 2015

Filed May 13, 2015 · 10-Q · 43 days after period end · 0001121781-15-000121

Q1 2015 · 10-Q

Revenue—

Net Income

-$1.25M

N/M vs Q1 2014

EPS Diluted

-$1.31

N/M vs Q1 2014

Same quarter

Metric	Q1 2015	Q1 2014	Q1 2013	Q1 2012
Revenue	—	$19.00K	$167.00K	$718.00K
Net Income	-$1.25M	-$1.56M	-$1.82M	-$1.01M
EPS Diluted	-$1.31	-$0.02	-$0.03	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR